Bioavailability of seocalcitol IV: evaluation of lymphatic transport in conscious rats

Mette Grove, Jeanet L Nielsen, Gitte P Pedersen, Anette Müllertz

    12 Citations (Scopus)

    Abstract

    PURPOSE: To study the use of long chain triglycerides (LCT) as a lymphotropic carrier of (3)H-seocalcitol by comparing the lymphatic transport and the portal absorption of (3)H-seocalcitol when dissolved in a (1) LCT solution or a (2) reference solution without lipid containing propylene glycol (PG). MATERIALS AND METHODS: A lymph cannulated conscious rat model was dosed orally with (3)H-seocalcitol dissolved in either LCT or PG. Lymph was collected continuously, and blood was sampled over 9 h. (3)H-seocalcitol in blood and lymph and triglycerides in lymph were analysed. RESULTS: A statistically significantly (p < 0.05) higher recovery of the dosed (3)H-seocalcitol was found in the intestinal lymph upon administration of the LCT solution (1.3 +/- 0.6%) compared to the PG solution (0.5 +/- 0.4%). The portal absorption of (3)H-seocalcitol was significantly (p < 0.05) higher from the LCT solution (16.2 +/- 2.2%) than from the PG solution (10.8 +/- 0.8%). CONCLUSIONS: The LCT solution resulted in a statistical significantly higher level of lymphatic and portal transport of (3)H-seocalcitol compared with the PG solution. However, even though LCT facilitates the formation of chylomicrons, (3)H-seocalcitol favours absorption directly to the portal blood probably due to the moderate lipophilicity of the molecule.
    Original languageEnglish
    JournalPharmaceutical Research
    Volume23
    Issue number11
    Pages (from-to)2681-8
    Number of pages7
    ISSN0724-8741
    DOIs
    Publication statusPublished - 2006

    Keywords

    • Former Faculty of Pharmaceutical Sciences

    Fingerprint

    Dive into the research topics of 'Bioavailability of seocalcitol IV: evaluation of lymphatic transport in conscious rats'. Together they form a unique fingerprint.

    Cite this